March 26, 2016 |
Federal authorities on Thursday charged three men in a fraud scheme that allegedly netted them close to $1 million. According to charging documents, the men worked for an inventory-management company in Radnor identified as "Company A," or a pharmaceutical company in New Brunswick, N.J., identified as "Company B. " While the companies were not named, "Company A" appears to be Storeroom Solutions Inc. and "Company B" appears to be Bristol-Myers Squibb,...
February 12, 2016 |
TransCelerate BioPharma Inc., a King of Prussia-based nonprofit organization that aims to find quicker and more efficient ways of producing new medicines, said Wednesday it was launching a subsidiary, BioCelerate, to improve efficiencies in preclinical research. Six pharmaceutical companies will be founding members of BioCelerate. The first initiative will be sharing toxicity data in preclinical studies, according to TransCelerate CEO Dalvir Gill. The six member drugmakers are: Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly & Co., GlaxoSmithKline, Novo Nordisk, and Shionogi & Co. email@example.com 215-854-2831 @LoydLinda
January 17, 2015 |
Adam Taliaferro, known for his against-the-odds recovery after a spinal-cord injury as a Pennsylvania State University football player, has been selected to fill former New Jersey Assemblywoman Celeste Riley's seat, Democratic officials said Thursday. Taliaferro, a Gloucester County freeholder, received endorsements from the Democratic committees in Gloucester, Salem, and Cumberland Counties to fill the Third District seat. "This opportunity arose, and for me, it was truly an exciting opportunity to really expand what we've been doing on the freeholder level, to bring it up to the state level," said Taliaferro, 33, of Woolwich.
September 19, 2014 |
Shares of DuPont Co. rose more than 5 percent Wednesday, to $69.25, after billionaire investor Nelson Peltz 's Trian Partners dropped the polite public mask he held up when he started accumulating shares last year and made it clear that he's had it with CEO Ellen Kullman 's resistance to his scheme to break apart the Wilmington manufacturer in hopes of fat shareholder payouts. Peltz and his partners, who specialize in squeezing big, old companies like H.J. Heinz and Pepsico , also vented disgust with DuPont corporate spending on "bureaucracy" and century-old hometown perks like the 217-room Hotel du Pont , the 1,252-seat DuPont Theatre , and the DuPont Country Club , with its three golf courses near the company's Wilmington headquarters.
April 8, 2014
The Philadelphia Police Foundation , a nonprofit organization that supports the Philadelphia Police Department, named the following board members: Paul K. Leary Jr. , attorney and member of the litigation department at Cozen O'Connor, Philadelphia; Stephen Olitsky , chief executive officer and president of B&B Wealth Management L.L.C., Gwynedd Valley; Tamar Olitsky , chief executive officer and president of the Olitsky Family...
January 12, 2014 |
What's good for some can be bad for others, and that maxim was demonstrated again last week with the release of the annual National Health Expenditures analysis. Though America spent just shy of $2.8 trillion in 2012 on health-care spending, the rate of growth was essentially flat, continuing a four-year trend, according to the study by the federal government's Office of the Actuary, Centers for Medicare and Medicaid Services, published in the journal Health Affairs. That is the longest period of slow or no growth in the 53-year history of the analysis.
June 12, 2013 |
Drugmaker AstraZeneca P.L.C. said Monday that it had agreed to pay up to $1.15 billion for Pearl Therapeutics Inc., a privately held company based in Redwood City, Calif. Pearl's research focus is inhaled medication for respiratory diseases, specifically chronic obstructive pulmonary disease (COPD). AstraZeneca is based in the United Kingdom but has operations in Wilmington and Newark, Del. AstraZeneca is trying to rebuild its portfolio after several blockbuster drugs lost patent protection, which translates to lower revenue because lower-cost generic competitors are allowed to enter the market.
June 1, 2013 |
Drugmaker Shire P.L.C. said Thursday it had halted plans to build a campus in Malvern and would remain in the Chesterbrook Corporate Center in Wayne. Shire is among the pharmaceutical companies of various sizes trying to reorganize in ways to meet investor demands for growth in revenue, profit, and stock price. Based in the United Kingdom, Shire accepted $3.45 million in state money to settle in Chesterbrook in 2004 with about 100 employees. In August, then-chief executive officer Angus Russell told The Inquirer that the 1,100 employees now there needed more room than the 425,000 square feet spread over four buildings.
May 22, 2013 |
Kurt W. Klein, 51, of Springfield, Delaware County, a claims adjuster and former director for the St. Francis of Assisi Catholic Youth Organization Athletic Program, died Wednesday, May 15, at home of complications from sarcoidosis, an inflammatory disease. Since 1992, Mr. Klein was employed by Professional Insurance Adjusters in Malvern, and before that by Bristol-Myers Squibb in Princeton. He never retired, said his son, Kurt D. Klein. But his true passion was the role he played as athletic director for the St. Francis of Assisi CYO program, starting in 1998, his family said.
July 4, 2012 |
Drugmakers AstraZeneca P.L.C. and GlaxoSmithKline P.L.C., both of which are based in the United Kingdom and have big operations in the Philadelphia region, have tried in the last few days to add external pieces to their pharmaceutical portfolios. Monday was the first day of stock trading after the Friday night announcement that Bristol-Myers Squibb Co. would acquire Amylin Pharmaceuticals Inc., and the role that AstraZeneca would play in the multipronged deal worth about $7 billion.